Respiratory syncytial virus (RSV), originally recovered from a colony of chimpanzees with
coryza and designated chimpanzee coryza agent, 1, 2 and human parainfluenza virus types …

With an increasing global incidence in children younger than the age of five, respiratory
syncytial virus (RSV) is one of the most common viral respiratory infections worldwide …

Since the early 1990s, nanotechnology has led to new horizons in nanomedicine, which
encompasses all spheres of science including chemistry, material science, biology, and …

Gene therapy for cystic fibrosis (CF) lung disease requires efficient gene transfer to airway
epithelial cells after intralumenal delivery. Most gene transfer vectors so far tested have not …

Chemokines are chemoattractant proteins that are divided into subfamilies based upon
cysteine signature motifs termed C, CC, CXC and CX3C. Chemokines have roles in …

Respiratory syncytial virus (RSV) is the leading cause of viral bronchiolitis and pneumonia in
infants and children. Currently, palivizumab is the only approved monoclonal antibody …

Wild-type human respiratory syncytial virus (HRSV) is a poor inducer of alpha/beta
interferons (IFN-α/β). However, recombinant HRSV lacking the NS1 and NS2 genes …

We examined the in vivo immune response of infants to natural respiratory syncytial virus
(RSV) infection through analysis of cytokine levels in nasal lavage fluid and stimulated …

We recently described the isolation of a novel paramyxovirus from children with respiratory
tract disease in The Netherlands. Based on biological properties and limited sequence …

Respiratory syncytial virus (RSV) is a major cause of viral lower respiratory tract infections
among infants and young children in both developing and developed countries. There are …